Clinical research on a global scale breaks paradigms and opens borders. We want to share this interview with Emma Bergoin, Medical and Communication Manager at Baahith CRO, the leading CRO in Saudi Arabia and the Middle East. Emma shares her unique experiences and insights on the evolution of clinical research services in Saudi Arabia and the significant contribution of women to strengthening the industry.
- What is the current role of women in the development of clinical research in Saudi Arabia?
In the context of clinical study management, the prominence of women in key roles, such as mine, is impactful. Women, in general, are healthcare leaders. There is a misconception that women face restricted opportunities within this field in Saudi Arabia, largely due to misinformation. Contrary to this belief, positions such as clinical research associates (CRAs) have five times more chances of being hired than their male counterparts and most CRCs are women. And even in complex phase 2 and 3 studies, women become Principal Investigators. Additionally, unlike in many other countries where a salary disparity may exist between genders, in Saudi Arabia and especially Baahith, I can assure you that compensation is equitable between genders. Truly, we’ve been playing a significant role in developing clinical studies.
- How would you explain to companies that want to conduct studies and have female staff that Saudi Arabia is a country with a culture that provides opportunities for both them and those looking to build their careers here?
It’s crucial to understand that this culture seeks to protect and empower women. Saudi Arabia is undergoing a remarkable cultural shift with women at the forefront. Saudi women are even stepping into previously male-dominated fields, like construction, manufacturing, etc. In 2020, for instance, 7,782 women joined the construction sector, defying old norms.
Allow me to share a personal experience. During my first visit to Saudi Arabia as a visitor from France, I encountered an individual who, I believe, refrained from shaking hands with me. I was unaware that in the local cultural context, it is customary for men to wait for women to initiate a handshake. This practice grants women the autonomy to decide if they feel comfortable and secure. It is about providing women the opportunity to make choices in a safe environment, and this value resonated deeply with me.
Vision 2030 reinforced these values, and reforms were implemented to incentivize and protect women in the workforce.
Speaking about educational opportunities, especially within industry-related doctoral and master’s programs, women constitute the majority of enrollees. This highlights the abundance of opportunities available to women.
- What do you think has changed for Saudi Arabia to now be a country with great openness in clinical research?
Vision 2030 aims to diversify the economy. Recognizing the critical role of medical research and clinical trials research services proving healthcare, the government has actively supported and promoted these endeavors. The government has substantial backing for medical research and development. This support has facilitated the establishment of research centers, streamlined regulatory processes, and encouraged collaboration with international partners.We have made significant alliances and efforts to showcase our resources, culture, and society in recent years.
The King Abdullah International Medical Research Center (KAIMRC) has become a notable center of excellence, earning accreditation to establish the nation’s inaugural Phase I clinical trial unit.
King Faisal Specialist Hospital and Research Center and the King Abdullah International Medical Research Center (KAIMRC) have established key alliances with domestic and international entities. These partnerships have enhanced internal capabilities and drawn in researchers eager to contribute to advancing Saudi Arabia’s scientific research field.
We have a very diverse healthcare infrastructure in Saudi.
Data from clinical trials, bio-bank collections, and genomic sequencing are available as open source. The King Abdullah International Medical Research Center (KAIMRC) promotes partnerships with other domestic and global entities, encouraging shared research endeavors.
- What are the significant benefits of conducting clinical studies in Saudi Arabia?
Saudi Arabia’s dedication to advancing its biotechnology infrastructure is evident. Cutting-edge research facilities outfitted with the latest technology stand ready to welcome CROs. The King Abdullah International Medical Research Center (KAIMRC) epitomizes this spirit of innovation, with laboratories filled with genomic sequencers, immunology assays, and cancer cell cultures, showcasing the country’s dynamic approach to scientific exploration.
Regulatory procedures have been optimized, ensuring faster approval processes. This CROs to quickly commence trials.
Public-private collaborations thrive in this environment, allowing CROs to partner with academic institutions, hospitals, and industry stakeholders.
Diverse Patient Populations:
The Kingdom represents a vibrant confluence of cultures, ethnicities, and health backgrounds. We have access to a varied patient demographic. This includes everything from rare genetic anomalies to conditions linked with lifestyle choices.The Saudi government provides appealing incentives to nurture growth, including tax exemptions, grants, and funding for clinical research organizations.
Beyond just clinical trials services, Saudi Arabia is like a goldmine of real-life insights. You’ve got electronic health records, patient registries, and all sorts of studies on the population at your fingertips.
We appreciate Emma for sharing her valuable experiences in Clinical Research Services in Saudi Arabia. Her insights on investment, educational opportunities, and study diversity have been enlightening. Her dedication to Baahith CRO and commitment to medical research is inspiring. We thank her for her time and look forward to continuing to learn from her expertise. Thank you, Emma!